Discover the physiological and developmental functions of X chromosome dosage using new genetic and system models

This project aims to uncover the mechanisms of X monosomy lethality and the role of sex chromosome dosage in development using advanced fly genetics and novel insect models.

Subsidie
€ 1.983.769
2025

Projectdetails

Introduction

Sex chromosomes are critical for controlling the phenotypic differences between males and females. However, they also create an imbalance in the gene products of sex-linked genes, with males having only one copy and females having two copies. To counteract this imbalance, many species evolved a chromosome-wide mechanism known as dosage compensation, which helps equalise gene expression between the sexes.

Importance of Dosage Compensation

This process is vital, as failed dosage compensation can lead to sex-specific disorders and lethality in several species, including humans. Although researchers have made significant progress in understanding the mechanistic basis of dosage compensation, the core questions remain unanswered:

  • Why is the lack of X-chromosome compensation lethal?
  • What are the physiological consequences of its absence?

Research Objectives

The proposed research aims to identify the mechanisms underlying X monosomy-associated lethality by studying the genes, cells, and developmental processes sensitive to X chromosome doses. This question has been poorly investigated partly due to the difficulties of studying sex chromosome effects.

Methodology

To overcome this barrier, we will investigate flies, as these permit the remarkable possibility of generating mosaic animals where sex chromosomes can be genetically manipulated in defined organs, and consequently, functional and molecular analysis.

Here, I will combine classical fly genetics, two novel model systems, and cutting-edge genomic techniques to:

  1. Identify the functions of X chromosome dosage in fly development.
  2. Characterise the ancestral X chromosome compensatory system of all insects.
  3. Discover the general shared functions of sex chromosome dosage in development using new insect model species.

Expected Impact

Thus, results from this research should have a major impact on our understanding of the importance of sex chromosome dosage in physiology and disease.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 1.983.769
Totale projectbegroting€ 1.983.769

Tijdlijn

Startdatum1-7-2025
Einddatum30-6-2030
Subsidiejaar2025

Partners & Locaties

Projectpartners

  • CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRSpenvoerder

Land(en)

France

Vergelijkbare projecten binnen European Research Council

ERC Starting...

Regulation of gene dosage on the mouse X chromosome

REGULADOSIX aims to uncover the evolutionary and functional mechanisms of X-chromosome inactivation in mammals by studying gene dosage compensation during mouse embryogenesis.

€ 1.954.154
ERC Consolid...

X-chromosome biology and immune health in females

XX-Health aims to uncover the role of X-inactivation escape genes in T-cell responses and sex differences in autoimmune disease risk using a novel TriX-Seq methodology in a large female cohort.

€ 1.998.891
ERC Starting...

Evolutionary Genomics of Unconventional Sex Chromosomes in Frogs

This project aims to investigate unconventional sex chromosome evolution in robber frogs, exploring recombination dynamics and genomic features to challenge existing models of sex chromosome development.

€ 1.499.950
ERC Starting...

Deciphering Gene Regulatory Networks governing Mammalian Sex Determination

This project aims to unravel the gene regulatory networks of mammalian sex determination using advanced techniques to enhance understanding of gonad development and related disorders.

€ 1.651.868
ERC Consolid...

Gene expression dosage as a driver of cellular and physiological traits

This project aims to characterize gene dosage-to-function relationships in human blood cells using genetic data and CRISPR techniques to enhance understanding of disease mechanisms and genomic medicine.

€ 1.993.059